JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB102884

FITC荧光偶联试剂盒 - Lightning-Link®

5

(3 Reviews)

|

(60 Publications)

FITC Conjugation Kit - Lightning-Link® (ab102884) offers several standout features:

- Rapid Conjugation: achieve FITC labeling in under 4 hours with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies, proteins, and peptides. FITC-labeled antibodies can be used immediately in applications such as Western blot, Flow cytometry, ELISA, and Immunohistochemistry (IHC) without further purification.
- Proven performance: cited in over 55 publications.
4 Images
Immunocytochemistry - FITC Conjugation Kit - Lightning-Link® (AB102884)
  • ICC

PubMed

Immunocytochemistry - FITC Conjugation Kit- Lightning-Link.

Lim, Tony KY, et al used FITC Conjugation Kit - Lightning-Link® (ab102884) as part of examining traumatic nerve injury. They used the kit to conjugate FITC to mouse anti-neurofilament 160/200 for use in immunohistochemistry.B, Contralateral nerves were stained for hypoxyprobe-1, DAPI, and neurofilament 160/200 (NF-M/L, axons). E, Ipsilateral nerves were subjected to the same staining. The area in proximity to the injury site is shown. Hypoxia, as shown by hypoxyprobe-1 staining, is observed in a region close to the injury site, in which axons, macrophages, and Schwann cells are all found to be hypoxic. This hypoxic region, in which nerve fibers were ligated, is delineated by the white dotted line. Areas outside of the dotted regions containing nonligated nerve fibers still have more hypoxyprobe deposition than contralateral nerves.

Image from Lim, Tony KY, et al., J Neurosci., 35(8):3346-59, doi: 10.1523/JNEUROSCI.4040-14.2015. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - FITC Conjugation Kit - Lightning-Link® (AB102884)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how Lightning-Link® labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for around 3 hours. Please see the ab102884 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Immunohistochemistry (PFA perfusion fixed frozen sections) - FITC Conjugation Kit - Lightning-Link® (AB102884)
  • IHC-FoFr

PubMed

Wills, Jonathan, et al used FITC Conjugation Kit - Lightning-Link® (ab102884) as part of examining the aggregation and co-localization of α-Syn with pGSK-3β and p-Tau in the striatum of A53T α-Syn mutant mice (A53T Tg) and wild-type mice (WT). They used the kit to conjugate FITC to Anti-p-GSK-3β (pY216) antibody for use in immunohistochemistry (PFA perfusion fixed frozen sections).
Right panels constitute merged image of left panels. Sections of striatum of A53T Tg and age-matched WT mice were stained with anti-α-Syn antibody conjugated to Texas Red (red) and anti-p-GSK3β conjugated to FITC (green). Nuclei were stained with DAPI (blue).

Image from Wills, Jonathan, et al., PLoS One, 6(3): e17953; doi: 10.1371/journal.pone.0017953. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Flow Cytometry - FITC Conjugation Kit - Lightning-Link® (AB102884)
  • Flow Cyt

PubMed

Flow Cytometry - FITC Conjugation Kit- Lightning-Link.

Weagel, Evita G., et al used FITC Conjugation Kit - Lightning-Link® (ab102884) as part of examining thymidine kinase 1 in lung, breast, and colorectal malignancies. They used the kit to conjugate FITC to three custom and a commercial anti-human thymidine Kinase 1 (TK1) antibodies for use in flow cytometry.
Membrane TK1 expression in of colon, breast, and lung cancer cell lines. Flow cytometry analysis of cell lines treated with anti-TK1 antibodies. a Quantification of TK1 expression on the cell membrane of HT-29 and SW620 cell lines stained with FITC or APC-conjugated anti-TK1 antibodies. b Quantification of TK1 expression on the cell membrane of MCF7 and MDA-MB-231 cell lines. The top bar graph shows MCF7 and MDA-MB-231 cell lines stained with FITC or APC-conjugated anti-TK1 antibodies. c Quantification of TK1 expression on the cell membrane of NCI-H460 and A549 cell lines stained with FITC or APC-conjugated anti-TK1 antibodies. Statistical analysis was performed by comparing the mouse isotype control fluorescent levels to those of A72, A74, CB1, or ab91651. *P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.001; ns = P > 0.05

Image from Weagel, Evita G., et al., Cancer cell international 18.1 (2018): 1-14. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

关键信息

产品详情

FITC Conjugation Kit / FITC Labeling Kit (ab102884) uses a simple and quick process for FITC labeling / conjugation of antibodies. It can also be used to conjugate other proteins or peptides. For a faster, newer protocol we recommend FITC Conjugation Kit ab188285 as an alternative

To conjugate an antibody to FITC using this kit:
- add modifier to antibody and incubate for 3 hrs
- add quencher and incubate for 30 mins

The FITC conjugated antibody can be used immediately in WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use. Learn about buffer compatibility below. Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Fluorescein Labeling Kit. 707-0005 is the same as the 100 μg size. 707-0010 is the same as the 3 x 100 ug size. 707-0030 is the same as the 3 x 10 ug size. 707-0015 is the same as the 1 mg size.

Amount and volume of antibody for conjugation to FITC

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 μg 3 x 10 μg 3 x 20 μg 3 x 10 μL
100 μg 1 x 100 μg 1 x 200 μg 1 x 100 μL
3 x 100 μg 3 x 100 μg 3 x 200 μg 3 x 100 μL
1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.

2 Ideal antibody concentration is 1mg/ml. 0.5 - 1 mg/ml can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/ml or < 0.5 mg/ml should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

规格

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab102884-3x10ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102884-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102884-CMP01" }, { "size":"3 x 10 µg", "name":"FITC mix", "number":"AB102884-CMP02" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab102884-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102884-CMP01" }, { "size":"3 x 100 µg", "name":"FITC mix", "number":"AB102884-CMP02" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102884-CMP03" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab102884-1mg", "assetComponentDetails": [ { "size":"1 x 1 mg", "name":"FITC mix", "number":"AB102884-CMP02" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102884-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102884-CMP03" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab102884-100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB102884-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB102884-CMP03", "productcode":"" }, { "size":"1 x 100 µg", "name":"FITC mix", "number":"AB102884-CMP02", "productcode":"" } ] } } }

性能和储存信息

运输条件
Ambient - Cannot Ship with Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
-20°C

产品实验方案

靶点信息

文献 (60)

Recent publications for all applications. Explore the full list and refine your search

Journal of biomedical science 32:59 PubMed40571942

2025

The ACE2 decoy receptor can overcome immune escape by rapid mutating SARS-CoV-2 variants and reduce cytokine induction and clot formation.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Shiu Lin,Tai-Ling Chao,Yu-Chi Chou,Yao Yi,Ci-Ling Chen,Kuo-Yen Huang,Sui-Yuan Chang,Pan-Chyr Yang

Journal of neuroinflammation 22:68 PubMed40055725

2025

Microglial progranulin differently regulates hypothalamic lysosomal function in lean and obese conditions via cleavage-dependent mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Chae Beom Park,Chan Hee Lee,Gil Myoung Kang,Se Hee Min,Min-Seon Kim

Scientific reports 15:1984 PubMed39809870

2025

Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Fang Wang,He Zhou,Yujie Zhang,Yu Da,Tiantian Zhang,Yanting Shi,Tong Wu,Jie Liang

JCI insight 10: PubMed39589812

2024

Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection.

Applications

Unspecified application

Species

Unspecified reactive species

Vicki Mercado-Evans,Holly Branthoover,Claude Chew,Camille Serchejian,Alexander B Saltzman,Marlyd E Mejia,Jacob J Zulk,Ingrid Cornax,Victor Nizet,Kathryn A Patras

Gels (Basel, Switzerland) 10: PubMed39195022

2024

Biohybrids for Combined Therapies of Skin Wounds: Agglomerates of Mesenchymal Stem Cells with Gelatin Hydrogel Beads Delivering Phages and Basic Fibroblast Growth Factor.

Applications

Unspecified application

Species

Unspecified reactive species

Farzaneh Moghtader,Yasuhiko Tabata,Erdal Karaöz

Nature medicine 29:2866-2884 PubMed37814059

2023

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel K Wilton,Kevin Mastro,Molly D Heller,Frederick W Gergits,Carly Rose Willing,Jaclyn B Fahey,Arnaud Frouin,Anthony Daggett,Xiaofeng Gu,Yejin A Kim,Richard L M Faull,Suman Jayadev,Ted Yednock,X William Yang,Beth Stevens

PLoS neglected tropical diseases 17:e0011621 PubMed37656766

2023

A structural classification of the variant surface glycoproteins of the African trypanosome.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Đaković,Johan P Zeelen,Anastasia Gkeka,Monica Chandra,Monique van Straaten,Konstantina Foti,Janet Zhong,Evi P Vlachou,Francisco Aresta-Branco,Joseph P Verdi,F Nina Papavasiliou,C Erec Stebbins

American journal of nuclear medicine and molecular imaging 13:107-117 PubMed37457328

2023

Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ayman Abouzayed,Wahed Zedan,Mohamed Altai,Joanna Strand,Anders Örbom

Cell reports 42:112049 PubMed36719797

2023

A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl.

Applications

Unspecified application

Species

Unspecified reactive species

Gianna Triller,Evi P Vlachou,Hamidreza Hashemi,Monique van Straaten,Johan P Zeelen,Yosip Kelemen,Carly Baehr,Cheryl L Marker,Sandra Ruf,Anna Svirina,Monica Chandra,Katharina Urban,Anastasia Gkeka,Sebastian Kruse,Andreas Baumann,Aubry K Miller,Marc Bartel,Marco Pravetoni,C Erec Stebbins,F Nina Papavasiliou,Joseph P Verdi

PLoS pathogens 19:e1011085 PubMed36706160

2023

A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Meng,Jialu Zha,Bingjie Zhou,Long Cao,Congli Jiang,Yuanfei Zhu,Teng Li,Lu Lu,Junqi Zhang,Heng Yang,Jian Feng,Zhifeng Gu,Hong Tang,Lubin Jiang,Dianfan Li,Dimitri Lavillette,Xiaoming Zhang
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com